Skip to main content

Advertisement

Log in

Poliomyelitis

Aktuelle Aspekte im arbeitsmedizinischen Kontext

Poliomyelitis

Current aspects in occupational medical issues

  • Übersichten
  • Published:
Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie Aims and scope Submit manuscript

An Erratum to this article was published on 21 June 2016

Zusammenfassung

Poliomyelitis (PM) ist eine virale Infektionskrankheit und wird durch das Poliovirus (PV) hervorgerufen. Die Bezeichnung Kinderlähmung entstand, da häufig Klein- und Schulkinder an der PM erkrankten. Die meisten Infektionen (> 95 %) verlaufen asymptomatisch. 0,1–1 % entwickeln eine Paralyse, die jedoch teilweise vollständig reversibel ist. Zur Diagnostik werden Proben aus Rachenspülwasser, Stuhl, Blut oder Liquor herangezogen. Mittels serologischem Antikörpernachweis (ELISA) oder PCR kann dann der direkte wie indirekte Nachweis der Infektion erfolgen. Seit 1954 gibt es eine präventive Schutzimpfung, die im Laufe der Jahre jedoch eine Anpassung erfahren hat. Diese Übersicht beinhaltet die aktuellen Erkenntnisse zum Thema PM unter besonderer Berücksichtigung arbeitsmedizinischer Aspekte.

Abstract

Poliomyelitis (PM) is an infectious viral disease caused by the poliovirus (PV). The term infantile paralysis was originally coined due to the propensity of the virus to affect children. Approximately 95 % of people who are affected by the virus are asymptomatic. Only 0.1–1 % of infected people show a certain degree of paralysis, which is however in some cases completely reversible. The diagnosis is usually made from samples of pharyngeal lavages, stool specimens, blood or cerebrospinal fluid samples. Direct or indirect detection of PV infections is carried out by serological antibody detection using an enzyme-linked immunosorbent assay (ELISA) or by the polymerase chain reaction (PCR). The first protective PM vaccine was developed in 1954 but has been modified over the course of time. This review outlines the current knowledge about PM with particular attention given to occupational medical issues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Baj A, Colombo M, Headley JL et al (2015) Post-poliomyelitis syndrome as a possible viral disease. Int J Infect Dis 35:107–116

    Article  PubMed  Google Scholar 

  2. Franck S, Allwinn R, Rabenau H et al (1999) Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV). Zentralbl Bakteriol 289:475–481

    Article  CAS  PubMed  Google Scholar 

  3. Garon J, Cochi S, Orenstein W (2015) The Challenge of Global Poliomyelitis Eradication. Infect Dis Clin North Am 29:651–665

    Article  PubMed  Google Scholar 

  4. Goncalves G, Santos L, Sarmento A et al (2003) [Portugal and Europe are poliomyelitis free]. Acta Med Port 16:33–39

    PubMed  Google Scholar 

  5. Kozic D, Turkulov V, Bjelan M et al (2014) Extensive myelitis after oral polio vaccination: MRI features. JBR-BTR 97:358–360

    CAS  PubMed  Google Scholar 

  6. Loucq C (2013) Vaccines today, vaccines tomorrow: a perspective. ClinExp Vaccine Res 2:4–7

    Article  CAS  Google Scholar 

  7. Mehndiratta M, Mehndiratta P, Pande R (2014) Poliomyelitis: historical facts, epidemiology, and current challenges in eradication. Neurohospitalist 4:223–229

    Article  PubMed  PubMed Central  Google Scholar 

  8. Platt L, Estivariz C, Sutter R (2014) Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis 210(Suppl1):S380–S389

    Article  PubMed  Google Scholar 

  9. Santos A, Costa EV, Oliveira S et al (2002) RT-PCR based analysis of cell culture negative stools samples from poliomyelitis suspected cases. J Clin Virol 23:149–152

    Article  CAS  PubMed  Google Scholar 

  10. Strauss R, Sagl M, Wewalka G et al (2008) [WHO Polio Eradication Programme:Status quo and implementation in Austria]. Wien Klin Wochenschr 120:210–216

    Article  PubMed  Google Scholar 

  11. Tajaldin B, Almilaji K, Langton P et al (2015) Defining Polio: closing the Gap in Global Surveillance. Ann Glob Health 81:386–395

    Article  PubMed  Google Scholar 

  12. Trallero G, Cabrerizo M, Avellon A (2013) [Role of the National Poliovirus Laboratory for the Program of eradication and poliomyelitis surveillance]. Rev EspSalud Publica 87:471–479

    Article  Google Scholar 

  13. Wiese-Posselt M, Tertilt C, Zepp F (2011) Vaccination recommendations for Germany. DtschArzteblInt 108:771–779, quiz 780

    Google Scholar 

  14. Wilton T, Dunn G, Eastwood D et al (2014) Effect of formaldehyde inactivation on poliovirus. J Virol 88:11955–11964

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Schöffel.

Ethics declarations

Interessenkonflikt

N. Schöffel, U. Drews, M.H.K. Bendels, D. Brüggmann und D.A. Groneberg geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag enthält keine Studien an Menschen oder Tieren.

Additional information

Diese Arbeit ist Bestandteil eines Promotionsverfahrens von Frau U. Drews.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schöffel, N., Drews, U., Bendels, M.H.K. et al. Poliomyelitis. Zbl Arbeitsmed 66, 92–94 (2016). https://doi.org/10.1007/s40664-016-0090-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40664-016-0090-z

Schlüsselwörter

Keywords

Navigation